Davis Polk & Wardwell is advising Nippon Paint Holdings Co., Ltd. on the transaction, Gibson Dunn & Crutcher is advising Lone Star Funds and Jamieson Corporate...
Nippon Paint Holdings’ $2.3 Billion Acquisition of AOC
MBX Biosciences’ $187.7 Million IPO
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
Terns Pharmaceuticals’ $172.7 Million IPO
Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...
MKS Instruments’ $1.4 Billion Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
Stoke Therapeutics’ $125 Million Upsized Common Stock Offering
Fenwick & West advised Stoke Therapeutics on the offering, Wilson Sonsini Goodrich & Rosati advised Stoke on IP matters and Davis Polk & Wardwell advised the...
iRhythm Technologies’ $661.25 Million Convertible Senior Notes Offering
Fenwick & West advised iRhythm Technologies, Inc. on the offering, and Davis Polk & Wardwell advised the initial purchasers. iRhythm Technologies, Inc. (Nasdaq: IRTC) announced its...
MicroStrategy’s $800 Million Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented MicroStrategy® Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. MicroStrategy Incorporated...
Intel’s $2.55 Billion Senior Notes Offering
Gibson, Dunn & Crutcher advised Intel Corporation on the offering, and Davis Polk & Wardwell advised the joint book-running managers. Intel Corporation (Intel) (Nasdaq:INTC) announced its $2.55...
Eli Lilly’s $6.5 Billion Senior Notes Offering
Covington & Burling and Kirkland & Ellis acted as special counsel to Eli Lilly and Company, while Davis Polk & Wardwell advised the joint book-running managers...
Bristol Myers Squibb’s $13 Billion Bond Offering
Kirkland & Ellis advised Bristol Myers Squibb on the offering, and Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters. Bristol...
Prime Medicine’s $161.0 Million Common Stock Offering
Goodwin Procter advised Prime Medicine and Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the transaction, while Davis Polk & Wardwell...
Gilead Sciences’ $4.3 Billion Acquisition of CymaBay Therapeutics
Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...